I’m excited to share a deeper look into my professional journey in oncology research, clinical development, and regulatory science. Over the past 30+ years, I’ve had the opportunity to work across global biopharma organizations, advisory boards, and academic institutions, all focused on advancing patient-centered innovation. Here is my biography.

I’m excited to share a comprehensive overview of my professional journey as a physician executive, highlighting my experience in clinical leadership, healthcare operations, and organizational transformation. Over the past 40+ years, I’ve had the privilege of working with incredible teams to drive patient safety, performance improvement, and strategic growth across complex healthcare systems. I look forward to continuing to contribute at the board level and support organizations in achieving excellence. Here is my biography.

I am excited to share a comprehensive biography that reflects my journey across global medical affairs, digital health innovation, pharmaceutical leadership, and patient-centered impact. Throughout my career, I’ve been fortunate to build high-performing teams, pioneer digital health solutions, collaborate with exceptional partners, and help organizations transform the way they serve patients.

I’m pleased to share a comprehensive biography that reflects my professional journey across clinical medicine, public health, and biopharmaceutical leadership. It highlights the experiences, values, and strategic insights that have shaped my four decades of work in advancing healthcare solutions and supporting the teams and organizations I’ve been privileged to serve.

I’m honored to share my professional biography, which reflects a career devoted to the development and commercialization of vaccines, anti-infectives, and diagnostics that address global microbial threats. My journey has taken me from regulatory service at the FDA to executive leadership in biotech and government programs shaping the future of infectious disease therapeutics.

Dr. Trudy Vanhove is a seasoned biopharmaceutical executive and venture partner with nearly 30 years of experience leading drug development, regulatory strategy, and corporate growth across biotech and pharmaceutical companies. She has played a pivotal role in launching multiple FDA- and EMA-approved therapies and has a strong track record in building high-performing teams, driving strategic partnerships, and supporting financing efforts. Fluent in several languages and with extensive international experience, Dr. Vanhove brings a unique global perspective and a deep scientific and business acumen to board roles and investment opportunities in the biotech sector.

I'm a global medical affairs leader with over two decades of experience spanning clinical research, regulatory strategy, and pharmaceutical innovation across Latin America and the United States. Throughout my career, I've had the privilege of guiding high-performing teams, launching impactful therapies, and aligning regional execution with global vision—most recently as Head of Medical Affairs for Emerging Therapy Areas at Novo Nordisk. Passionate about advancing patient outcomes and fostering collaborative leadership, I bring a strategic, people-centered approach to everything I do in the healthcare space.

I’m a pharmacist and consultant with over 25 years of experience spanning the pharmaceutical industry, regulatory affairs, and academia. My career has been driven by a passion for translating complex regulatory requirements into clear, actionable strategies that help companies innovate responsibly. Through leadership roles in both industry and consulting, I’ve had the privilege of mentoring professionals, teaching at top pharmacy schools, and partnering with organizations to align science, compliance, and strategic growth. I’m always excited to connect with others who are committed to elevating healthcare and advancing thoughtful, compliant innovation.

Dr. Larrye Ellis Loss, PharmD, MBA, is a global pharmaceutical executive and consultant with over 40 years of experience leading clinical development, medical affairs, and strategic operations across the life sciences industry. With a distinguished career at AstraZeneca and current advisory work through his own consultancy, Larrye brings deep expertise in drug development, regulatory strategy, and cross-functional leadership. He is known for his integrity, global perspective, and commitment to mentoring the next generation of healthcare professionals. Passionate about service, he also dedicates his time to nonprofit leadership and disaster relief with the American Red Cross.

Mary Hames is a seasoned Medical Affairs executive with a proven track record of leading high-performing teams and delivering strategic impact across rare disease, diagnostics, and oncology. With a foundation in biochemical genetics and over a decade of industry experience, she has played pivotal roles in clinical operations, launch preparedness, and cross-functional leadership. Known for her ability to navigate complex medical landscapes, Mary has successfully built and led medical teams, advanced companion diagnostics, and driven field strategy across multiple therapeutic areas. Her leadership is marked by scientific rigor, operational excellence, and a deep commitment to improving outcomes for patients with rare and life-threatening conditions.

I am excited to share my executive biography, highlighting my journey in oncology, clinical research, and medical affairs over the past 25 years. From my work as a medical science liaison to my leadership in pharmacy education and healthcare consulting, I have been committed to advancing patient care, scientific innovation, and medical education. If you're interested in learning more about my background, expertise, and contributions to pharmaceutical sciences and healthcare strategy.

I am excited to share my executive biography, which highlights my journey in medical affairs, pharma sales, and scientific exchange. With over 22 years of experience leading high-performing teams, optimizing strategic execution, and driving AI-enabled learning, I am passionate about advancing patient outcomes and fostering innovation in healthcare. I am currently seeking board opportunities to expand my influence and contribute my expertise beyond my current space.

Matthew Smollin, PharmD, is an accomplished leader in medical affairs and clinical innovation with over 15 years of clinical experience and a decade of industry expertise spanning clinical research, regulatory strategy, and team leadership. As Vice President of Medical Affairs at Karius, Inc., he directs medical and scientific strategies, guiding breakthrough advancements in molecular diagnostics while navigating complex FDA and Medicare regulatory processes. Throughout his career, he has successfully built and managed high-performing teams, fostered strong relationships with key opinion leaders, and played a pivotal role in clinical trial design, publication strategy, and scientific engagement. A respected speaker and thought leader, Dr. Smollin’s expertise in infectious disease diagnostics and next-generation sequencing has shaped industry best practices and advanced clinical innovation. His dedication to scientific excellence, strategic vision, and ability to translate complex medical insights into impactful solutions make him a driving force in the evolution of precision medicine and diagnostic technologies.